A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets

NCT05215639 · clinicaltrials.gov ↗
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie